Circulating biomarkers to monitor cancer progression and treatment

Circulating biomarkers to monitor cancer progression and treatment

Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Suthee Rapisuwon, Eveline E. Vietsch, Anton Wellstein
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2016-01-01
Sraith:	Computational and Structural Biotechnology Journal
Ábhair:	cell-free DNA cell-free RNA cell-free microRNA cell-free circulating nucleic acids circulating tumor DNA circulating mutant DNA
Rochtain ar líne:	http://www.sciencedirect.com/science/article/pii/S2001037016300113

Míreanna comhchosúla

Circulating cell-free nucleic acids of plasma in human aging, healthy aging and longevity: current state of knowledge
de réir: Nicolas P. Tessier, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
de réir: Hyun-Ji Lee, et al.
Foilsithe / Cruthaithe: (2018-09-01)

The Role of Circulating Biomarkers in Lung Cancer
de réir: Sayuri Herath, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Liquid biopsy in gallbladder carcinoma: Current evidence and future prospective
de réir: Sridhar Mishra, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
de réir: Pablo J. Dopico, et al.
Foilsithe / Cruthaithe: (2022-03-01)

New Year, New Name and New Milestones Scope - Journal of Circulating Biomarkers
de réir: Shidong Jia, et al.
Foilsithe / Cruthaithe: (2014-04-01)

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
de réir: Anelis Maria Marin, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Liquid biopsy: paving a new avenue for cancer research
de réir: Keerthi Kurma, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
de réir: Wei Zhang, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
de réir: Pavel Stejskal, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma
de réir: Shuchan Li, et al.
Foilsithe / Cruthaithe: (2023-03-01)

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms
de réir: Lisanne F. vanDessel, et al.
Foilsithe / Cruthaithe: (2019-02-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
de réir: Xianliang Cheng, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular CarcinomaSummary
de réir: Xueying Lyu, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> System
de réir: Gabrielle Wishart, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives
de réir: Diana Galoș, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma
de réir: Linlin Yan, et al.
Foilsithe / Cruthaithe: (2018-02-01)

The role of liquid biopsy in the diagnosis of glioblastoma progression
de réir: A. I. Ryabova, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer
de réir: Shijie Li, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Circulating tumor DNA, a new tool for diagnosing and monitoring cancer patients?
de réir: Bente Risberg, et al.
Foilsithe / Cruthaithe: (2016-01-01)

The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis
de réir: Bronkhorst Abel Jacobus, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Opportunities and challenges of circulating biomarkers in neuroblastoma
de réir: Ricky M. Trigg, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?
de réir: Negin Ghiyasimoghaddam, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
de réir: Andrey Turchinovich, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Cardiomyocyte-Specific Circulating Cell-Free Methylated DNA in Esophageal Cancer Patients Treated with Chemoradiation
de réir: Sarah Martinez Roth, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Quantifying cell free DNA in urine: comparison between commercial kits, impact of gender and inter-individual variation
de réir: Greta Streleckiene, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Investigation of circulating DNA integrity after blood collection
de réir: Oriane Cédile, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
de réir: Jee‐Soo Lee, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Current Trends in Circulating Biomarkers for Melanoma Detection
de réir: Nancy Huang, et al.
Foilsithe / Cruthaithe: (2022-04-01)

A Systematic Review of miRNA and cfDNA as Potential Biomarkers for Liquid Biopsy in Myocarditis and Inflammatory Dilated Cardiomyopathy
de réir: Piotr Lewandowski, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Advances in diagnosis and evaluation of lymphoma through the detection of circulating cell free DNA
de réir: BAI Xiao-teng, SUN Xiao-hong, ZHAO Xiang-yu, LI Zi-jian
Foilsithe / Cruthaithe: (2022-04-01)

Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities
de réir: Elena Trevisi, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Changes in circulating cell-free nuclear DNA and mitochondrial DNA of patients with adolescent idiopathic scoliosis
de réir: Jiong Li, et al.
Foilsithe / Cruthaithe: (2019-10-01)

Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study
de réir: Andrew Condappa, et al.
Foilsithe / Cruthaithe: (2020-09-01)

The Prospect and Challenges to the Flow of Liquid Biopsy in Africa
de réir: Dada Oluwaseyi Temilola, et al.
Foilsithe / Cruthaithe: (2019-08-01)

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
de réir: Margaret Ottaviano, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
de réir: Yen-Han Tseng, et al.
Foilsithe / Cruthaithe: (2024-01-01)

cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
de réir: Elodie Bohers, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
de réir: Marinella Corbetta, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Whole genome sequencing of low input circulating cell‐free DNA obtained from normal human subjects
de réir: Julie F. Foley, et al.
Foilsithe / Cruthaithe: (2021-08-01)